Gaucher Disease

• FDA approval · 2013-03-26
  FDA Approved: VPRIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for VPRIV (velaglucerase alfa) submitted by Takeda Pharmaceuticals America, Inc.

• FDA approval · 2012-05-01
  FDA Approved: ELELYSO — Original Application (Pfizer Laboratories Div Pfizer Inc)

  FDA approved ELELYSO (taliglucerase alfa) from Pfizer as the original application for Gaucher disease. This approval introduced the first pl…

• FDA approval · 2010-02-26
  FDA Approved: VPRIV — Original Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved VPRIV (velaglucerase alfa) from Takeda as the original approval for the treatment of Gaucher disease.

• FDA approval · 2008-02-29
  FDA Approved: ZAVESCA — Supplemental Application (Actelion Pharmaceuticals US, Inc.)

  FDA issued a supplemental approval for ZAVESCA (miglustat) from Actelion Pharmaceuticals US, Inc.